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INTRODUCTION
Rheumatoid arthritis (RA) is a systemic and inflammatory auto-
immune disease (1). Uncontrolled RA causes joint damage, disabil-
ity, increases the risk of cardiovascular and other co-morbidities,
and can result in a lower quality of life (2). In most cases, the meta-
carpophalangeal and proximal interphalangeal joints of the fin-
gers, the interphalangeal joints of the thumbs, the wrists, and the
metatarsophalangeal (MTP) joints of the toes are affected in the
early stages of the disease (3, 4). Other joints of the upper and
lower limbs, such as the elbows, shoulders, ankles, and knees, are
also commonly impaired. Although the foot is commonly affected
by RA (5-10), it is rarely addressed in routine clinical practice (11).
Foot deformity and pain adversely affect activities of daily living
by limiting the person’s ability to walk (12, 13), and also have an
adverse effect on the quality of life (14). Hence, resection arthro-
plasty is often performed to treat deformities of the forefoot in pa-
tients with RA (15, 16).
The Disease Activity Score in 28 Joints (DAS28) (17) is fre-
quently used as an indicator of disease activity in RA. However,
one limitation of DAS28 is the inclusion of only the knee joint in
the evaluation of affected joints of the lower extremities. van der
Leeden et al. (18) evaluated the forefoot of patients with RA who
were classified as in remission based on DAS28 during the first
8 years after disease onset, and reported that pain or swelling
were present in at least one of the MTP joints in 40% of patients.
Wechalekar et al. (19) evaluated the ankle and foot joints of pa-
tients with RA who met the criteria for remission according to
DAS28 and reported that synovitis of the forefoot was found in 43%
of patients.
The Health Assessment Questionnaire-Disability Index (HAQ-
DI) (20) has been widely used to evaluate disability in patients with
RA (21), and has also been used as an indicator of functional re-
mission (HAQ remission) (22). Rojas-Villarraga et al. (23) re-
ported that movement pain in the forefoot was associated with
disease activity (DAS28) and disability (HAQ-DI).
The Foot Function Index (FFI) (24) is commonly used to evalu-
ate foot-related disorders such as RA (25-27). Bal et al. (28) re-
ported that the HAQ-DI was the most important correlate of FFI
and its subscales.
It is unclear how improvement of foot function in patients with
RA who undergo resection arthroplasty affects disease activity and
disability. Therefore, the purpose of this study was to investigate
the changes in foot function, disease activity, and disability in pa-
tients with RA after resection arthroplasty.
PATIENTS AND METHODS
We identified 12 patients who fulfilled the American College of
Rheumatology (ACR) revised criteria for rheumatoid arthritis (29),
who had marked forefoot deformities and pain, and underwent
resection arthroplasty of the forefoot (30) at the Utazu Hama Clinic
(currently Utazu Hospital), Kagawa Prefecture, Japan, between
July 2008 and January 2012. One patient was excluded from the
study because the patient was admitted to another hospital 1 year
after the surgical procedure. The resection arthroplasty of the
forefoot is composed of excision of all metatarsal heads through
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incision of the medial site of the hallux and the planta. Figure 1
shows the plain radiographs before and after the forefoot resection
arthroplasty. Written informed consent was obtained from each
patient and the study protocol was approved by the ethics com-
mittee of Tokushima University Hospital.
Patient characteristics, including age, gender, body mass index
(BMI), disease duration, and prescribed drugs, were obtained
from medical records.
All study patients underwent clinical assessment for foot func-
tion, disease activity, and physical function, preoperatively and 1,
3, and 12 months after surgery.
Dysfunction in the foot was evaluated using the FFI, which uses
a visual analog scale for pain, disability, and limitation of activity.
The scale consists of 23 items divided into three subscales : pain
(9 items), disability (9 items), and limitation of activity (5 items).
Patients were asked to record the most appropriate score for each
condition on a line. To calculate the subscale scores, the sum of
the values for each item was calculated and divided by the number
of items that were applicable to each individual patient. By calcu-
lating the average of the three subscale scores, the total FFI score
(FFI total) was determined. Each score ranges from 0 to 100, with
higher scores corresponding to more severe pain and disability,
and greater limitation of activity. These calculations were carried
out by physicians and trained physical therapists.
Disease activity was assessed using DAS28-C-reactive protein
(CRP) (31-32). The DAS28-CRP score was calculated using the
number of tender joints and swollen joints out of 28 joints, the Pa-
tient Global Assessment (PtGA) score, and CRP level.
Disability was evaluated using the HAQ-DI, which is composed
of eight categories : dressing and grooming ; arising ; eating ; walk-
ing ; hygiene ; reach ; grip ; and activities. There are two to three
questions per category, with a total of 20 questions. Patients re-
port the amount of difficulty they have in performing these activi-
ties : “without any difficulty”, “with some difficulty”, “with much
difficulty”, and “unable to do”, with 0, 1, 2, or 3 points assigned,
respectively. The overall HAQ-DI score is obtained by dividing
the sum of the highest points of each category by 8 (range : 0-3
points).
Statisticalanalysis
Descriptive statistics were presented using median (range) and
meanstandard deviations for continuous variables. Qualitative
data were presented as frequencies and percentages. Repeated
measures analysis of variance was used to evaluate the effects of
resection arthroplasty of the forefoot on changes in foot-related
function, disease activity, and disability. If the null hypothesis was
rejected, the paired t- test was used to compare foot function, di-
sease activity, and disability preoperatively and 1, 3, and 12 months
after surgery. In this analysis, P0.017 (0.05/3) was considered
to be statistically significant using the Bonferroni method. To in-
vestigate the correlations between foot function, disease activity,
and disability, we analyzed the correlation between the extent of
change preoperatively and 1, 3, and 12 months after surgery using
Spearman’s rank correlation coefficient. In this analysis, P0.05
was considered statistically significant.
Statistical analyses were performed using the PASW Statistics
version 18 (IBM Co., Armonk, NY, USA) and SAS software version
8.2 (SAS Institute, Cary, NC).
RESULTS
Patient characteristics are presented in Table 1. Eleven patients
(nine women and two men, with a mean age of 65.3 years) par-
ticipated in the study. The mean BMI was 21.9 kg/m2, and mean
disease duration of RA was 20.3 years. Disease-modifying anti -
rheumatic drugs (DMARDs) and non-steroidal anti - inflammatory
drugs (NSAIDs) were prescribed in approximately 50% of patients.
Methotrexate (90.9%) and corticosteroids (81.8%) were the most
commonly prescribed drugs in the study group. Biologic drugs
were prescribed in 27.3% of patients ; tocilizumab (Actemra) was
not licensed for use at the time of the study. There were no sub-
stantial changes in the prescribed drugs during 12 months after
the surgery. Seven patients underwent bilateral forefoot resection
arthroplasty ; four patients underwent unilateral forefoot resection
arthroplasty, of which, two had previously undergone a similar pro-
cedure on the contralateral foot.
Table 2 summarizes the values for FFI total and subscale scores
(FFI pain, FFI disability, FFI limitation of activity) at each assess-
ment stage. The scores for FFI total, FFI pain, FFI disability, and
FFI limitation of activity scores for the affected foot showed signifi-
cant improvements (P0.001, P0.001, P0.001, and P=0.002,
respectively). The differences in scores were significant in all but
one pair when preoperative parameters were compared with those
at 1, 3, and 12 months after surgery. The exception was the change
in FFI limitation of activity score preoperatively and at 1 month after
surgery.
The changes in DAS28-CRP and its subscales are presented in
Table 3. There were significant improvements in DAS28-CRP,
Figure 1. Plain radiographs before (A) and after (B) the forefoot resec-
tion arthroplasty
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Table 1. Clinical characteristics of patients with rheumatoid arthritis at baseline (n=11)
Characteristics Value
Age (years)a 65.37.2 (51 -72)
Sex (women/men)b 9/2
Body mass index (kg/m2)a 21.92.1 (17.9 -25.6)
Duration of disease (years)a 20.38.0 (5 -33)
Medication (%)c
NSAIDs 54.5
DMARDs 45.5
Methotrexate 90.9
Corticosteroid 81.8
Biologics 27.3 (tocilizumab=0)
Forefoot resection arthroplastyb
Bilateral 7
Unilateral 4
History of prior arthroplasty (done/none) 2/2
CRP (mg/dl)a 0.530.53 (0.06 -1.47)
FFIa 49.2517.83 (23.40 -76.90)
DAS28-CRPa 3.870.87 (2.68 -5.03)
HAQ-DIa 1.280.68 (0 -2.38)
NSAIDs, non-steroidal anti - inflammatory drugs ; DMARDs, disease -modifying antirheumatic drugs ;
CRP, C-reactive protein ; FFI, foot function index ; DAS28, disease activity score in 28 joints ;
HAQ-DI, health assessment questionnaire -disability index.
ameanstandard deviation (range).
bnumber.
cpercentage.
Table 2. Values of the FFI total and its subscale in patients with rheumatoid arthritis
Variable MeanSD Median (range)
P -value
repeated measures
ANOVA paired t - test
FFI total P0.001
preoperative 49.2517.83 53.76 (23.40 -76.90)
postoperative 1 month 28.8011.11 35.04 (14.10 -44.24) P0.001
postoperative 3 months 18.839.26 15.33 (6.90 -35.10) P0.001
postoperative 12 months 16.8719.15 11.70 (1.86 -67.65) P=0.001
FFIpain P0.001
preoperative 50.1621.59 51.10 (13.71 -86.10)
postoperative 1 month 21.6913.99 22.57 (0.71 -48.57) P0.001
postoperative 3 months 10.396.26 10.14 (1.88 -26.29) P0.001
postoperative 12 months 12.9023.07 2.14 (0 -74.30) P=0.001
FFIdisability P0.001
preoperative 57.4823.50 56.67 (17.44 -85.70)
postoperative 1 month 38.5814.28 42.00 (18.67 -68.22) P=0.002
postoperative 3 months 28.1713.77 30.78 (8.89 -53.11) P=0.001
postoperative 12 months 22.2520.83 18.00 (1.89 -74.56) P=0.003
FFIactivity limitation P=0.002
preoperative 32.6419.59 35.60 (0 -54.00)
postoperative 1 month 21.6417.01 15.40 (0 -45.80) P=0.086
postoperative 3 months 14.1813.13 13.80 (0 -35.20) P=0.007
postoperative 12 months 13.8515.62 11.00 (0 -47.20) P=0.015
SD, standard deviation ; ANOVA, analysis of variance ; FFI, foot function index.
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PtGA, and swollen joint counts (P=0.033, P=0.038, and P=0.008,
respectively). However, the CRP and tender joint count did not
improve significantly (P=0.892, and P=0.492, respectively). Com-
pared with preoperative values, the postoperative parameters for
DAS28-CRP at 1 and 3 months after surgery, PtGA at 1 month after
surgery, and postoperative counts of swollen joints at 1 and 3
months after surgery were significantly improved.
The changes in HAQ-DI and HAQ-walking are shown in Table
4. There were no significant changes in HAQ-DI or HAQ-walking
(P=0.150 and P=0.597, respectively).
Finally, we analyzed the correlation for changes in foot function,
disease activity, and disability, at 1, 3, and 12 months after surgery
compared with preoperative values, using Spearman’s rank cor-
relation coefficient. However, there was no significant correlation
within any pairs (data not shown).
DISCUSSION
In this study, we investigated the relationship between foot func-
tion and changes in the disease activity and disability after resec-
tion arthroplasty of the forefoot. The total and all three subscales
of foot function were significantly improved after surgery, which
is consistent with results from previous studies (33, 34).
The DAS28 is the most widely used method for measuring dis-
ease activity in RA. As discussed previously, the inclusion of only
28 joints in DAS28 is controversial. A committee consisting of mem-
bers of ACR/European League Against Rheumatism (EULAR)
analyzed the data of previous studies regarding the validity of joint
counts (35). Its review showed that disease activity often persisted
in the foot and foot joint even though patients were judged to be
in remission on the basis of the 28 joint score. However, the PtGA
was found to be a more reflective measurement of swelling and/
or tenderness in the joints not covered by DAS28, as most patients
had high scores for the PtGA (35-37). Additionally, our study re-
sults showed that the PtGA score improved significantly with im-
provement of foot function. Although a significant improvement
was observed in relation to the number of swollen joints, no sig-
nificant difference was observed in CRP level or in the number of
tender joints after resection arthroplasty. The reason for the sig-
nificant improvement in the number of swollen joints is unknown.
However, our results highlight the importance of verifying changes
in the subscales of DAS28. On the other hand, the reason for the
lack of significant difference in CRP may be that the levels were
rather low even before the surgery, and the amount of postopera-
tive change was expected to be small.
Our results showed that there was no significant difference be-
tween pre- and postoperative scores for HAQ-DI and HAQ-walk-
ing. Aletaha et al. (38), studied the use of HAQ-DI for patients in
remission from six clinical trials, and reported that disability in RA,
as measured by HAQ-DI, is composed of reversible and irrevers-
ible components. As disability is affected by aging (39, 40), scores
for HAQ-DI are worse in older patients. Longer disease duration
is also associated with impaired foot function and a decrease in
walking speed (41). Our study patients had a mean age of 65.3
years, and a long disease duration, mean of 20.3 years. Therefore,
Table 3. Values of the DAS28-CRP and its subscale in patients with rheumatoid arthritis
Variable MeanSD Median (range)
P -value
repeated measures
ANOVA paired t - test
DAS28-CRP P=0.033
preoperative 3.870.87 3.98 (2.68 -5.03)
postoperative 1 month 3.111.04 3.28 (1.47 -4.70) P=0.006
postoperative 3 months 3.001.31 2.97 (1.28 -5.59) P=0.011
postoperative 12 months 3.470.86 3.43 (2.32 -4.93) P=0.202
PtGA P=0.038
preoperative 46.4530.91 47 (4 -99)
postoperative 1 month 25.3623.74 24 (0 -77) P=0.007
postoperative 3 months 28.1832.55 9 (0 -92) P=0.066
postoperative 12 months 34.1831.29 23 (4 -99) P=0.018
CRP P=0.892
preoperative 0.530.53 0.22 (0.06 -1.47)
postoperative 1 month 0.520.46 0.40 (0.03 -1.22) P=0.931
postoperative 3 months 0.420.59 0.19 (0.06 -1.97) P=0.535
postoperative 12 months 0.580.89 0.28 (0.06 -3.13) P=0.825
Tender joint counts P=0.492
preoperative 5.093.36 5 (1 -13)
postoperative 1 month 3.452.77 4 (0 -9) P=0.111
postoperative 3 months 4.003.52 5 (0 -10) P=0.232
postoperative 12 months 4.733.77 3 (1 -12) P=0.811
Swollen joint counts P=0.008
preoperative 3.641.75 4 (1 -6)
postoperative 1 month 2.181.66 3 (0 -5) P=0.002
postoperative 3 months 1.451.44 1 (0 -4) P=0.002
postoperative 12 months 2.641.96 3 (0 -5) P=0.153
SD, standard deviation ; ANOVA, analysis of variance ; DAS28-CRP, disease activity score in 28 joints -C-reactive protein ;
PtGA, patient global assessment.
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we believe that improvements in disability were difficult to achieve
because of the irreversible components. Additionally, we infer that
improvement of foot function had little effect on disability because
there is low coverage of lower limb function in the HAQ-DI. Wells
et al. (42) showed that minimal differences in HAQ-DI, recognized
as “somewhat better” by patients (minimal clinically important dif-
ferences), was 0.22. Our data showed that the difference observed
at 3 months postoperatively was only 0.29, and it can be assumed
that the patients were not aware of any improvement in disability.
Forefoot involvement has been reported to occur in the early
stages of RA following disease onset (10, 43, 44). Although involve-
ment of the foot and ankle joint is common in patients with RA, it
is rarely addressed as a clinical problem (45). Therefore, aware-
ness of this involvement is important in order to maintain optimal
foot function and prevent disability. Foot function should be evalu-
ated regularly and any problems should be treated appropriately
at an early stage. The purpose of treating the foot and foot joints
in patients with RA is to provide pain relief and maintain the ability
to walk(46).
The first limitation of the present study is that the number of
cases was small. The second limitation is that the study included
both patients who underwent bilateral surgery and those who un-
derwent unilateral surgery. Because of small numbers, we did
not present the results in the bilateral and unilateral surgery groups
separately. However, the values of FFI total, FFI pain, FFI disability,
FFI activity limitation, PtGA, HAQ-DI and HAQ-walking were
somewhat lower in patients who underwent bilateral surgery, es-
pecially 12 months after the surgery. The third limitation is that
HAQ-DI was not evaluated using the validated Japanese version.
However, a strong correlation has been reported (47) between the
original index used in the current study and the Japanese version
of HAQ-DI (r=0.993) ; and we therefore believe that this limitation
would have only a small effect on the results. One strength of this
study is that patients were evaluated preoperatively and followed
up for up to 12 months postoperatively, with a total of four evalu-
ations within this period.
In conclusion, dysfunction of the foot improved significantly
after resection arthroplasty of the forefoot, and this improvement
had duration of 12 months postoperatively. Significant improve-
ments were also demonstrated for DAS28-CRP, as a measure of
disease activity, and its subscales, PtGA and swollen joint count.
In comparison, HAQ-DI as a measure of disability and its subscale,
HAQ-walking, did not show significant improvements.
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